Table 2.
Lysins under investigation for WHO critical category of priority pathogens.
Sr. No. | Lysin | Enzymatic activity | Modifications | Outer membrane permeabilizers | Target bacteria | References |
---|---|---|---|---|---|---|
1 | EndoT5 | Peptidase | – | Polymyxin B, gramicidin D, poly-l-lysine, chlorhexidine, and miramistin | E. coli | Shavrina et al. (2016) |
l2 | Lysep3-D8 | Lysozyme (Muramidase) | Fusing B. amyloliquefaciens bacteriophage lysin binding domain D8 to the C-terminal region of Lysep3 | – | E. coli, P. aeruginosa, A. baumannii, and Streptococcus strain | Lv et al. (2015) and Wang et al. (2017) |
3 | Colicin-Lysep3 | Lysozyme (Muramidase) | N-terminal translocation region and central receptor binding region of colicin A fused with Lysep3 | – | E. coli | Lv et al. (2015) and Yan et al. (2017) |
4 | Lysep3 + aa | Lysozyme (Muramidase) | Fusing 5,10, and 15 cationic amino acid polypeptide and a polypeptide including both cationic and hydrophobic aa to the C-terminus of Lysep3 to obtain four fusion lysins (5aa, 10aa, 15aa, and mix). | EDTA and citric acid | E. coli | Lv et al. (2015) and Ma et al. (2017) |
5 | Lysin KP27 | Endopeptidase | – | – | K. pneumoniae, P. aeruginosa, S. Typhimurium, and E. coli | Maciejewska et al. (2017a) |
6 | APgp15 | Lysozyme (Muramidase) | – | Chloroform | E. coli, K. pneumoniae, P. aeruginosa, B. enocepacia, and S. Typhimurium | Maciejewska et al. (2017b) |
7 | Ply3a03 and PlyPa03 | Lysozyme (Muramidase) | – | – | P. aeruginosa | Raz et al. (2019) |
8 | gp144 | Transglycosylase | – | – | P. aeruginosa, E. coli, S. aureus, and B. cereus | Paradis-Bleau et al. (2007) |
9 | EL88 | Transglycosylase | – | EDTA, citric acid, poly-l-lysine, and polymyxin B nonapeptide (PMBN) | P. aeruginosa | Briers et al. (2008) and Briers et al. (2011) |
10 | Art-175 | Transglycosylase | Fusing P. aeruginosa lysin KZ144 to a sheep myeloid peptide (SMAP-29) having antimicrobial properties | EDTA | E. coli, P. aeruginosa, and A. baumannii | Briers et al. (2009), Briers et al. (2014a), Defraine et al. (2016), and Schirmeier et al. (2018) |
11 | PyS2-GN4 | Transglycosylase | Fusing P. aeruginosa bacteriocin pyocin S2 (PyS2) domains I to III to the P. aeruginosa phage PAJU2 lysin GN4 | – | P. aeruginosa | Heselpoth et al. (2019) |
12 | LysPA26 | Lysozyme (Muramidase) | – | – | E. coli, P. aeruginosa, A. baumannii, and K. pneumoniae | Guo et al. (2017), Murray et al. (2021) |
13 | LoGT-008 | Lysozyme (Glycoside hydrolase) | Polycationic nonapeptide fused to the N terminal of PVP-SE1gp146 | EDTA | P. aeruginosa and A. baumannii | Briers et al. (2014b) and Abdelrahman et al. (2021) |
14 | LysAB2 | Muramidase | – | – | A. baumannii, E. coli, and S. aureus | Lai et al. (2011) |
15 | LysAB2 P3 | Muramidase | – | – | A. baumannii | Peng et al. (2017) |
16 | PlyF307 | Muramidase | – | – | A. baumannii | Lood et al. (2015) |
17 | PlyE146 | Muramidase | – | – | E coli, P. aeruginosa, and A. baumannii | Larpin et al. (2018) |
18 | ElyA1 | Muramidase | – | – | P. aeruginosa, A. baumannii, and K. pneumoniae | Blasco et al. (2020) and Lai et al. (2020) |
19 | P307SQ-8C | Muramidase | Eight aa (SQSRESQC) from the hepatitis B virus fused to the C-terminal of P307 | A. baumannii | Thandar et al. (2016) | |
20 | LysABP-01 | Muramidase | – | – | A. baumannii | Thummeepak et al. (2016) |
21 | PlyAB1 | Glycoside hydrolase | – | – | A. baumannii | Huang et al. (2014) |
22 | Abgp46 | Muramidase | – | EDTA, citric acid, and malic acid | A. baumannii, P. aeruginosa, and S. Typhimurium | Oliveira et al. (2016) |
23 | Ply6A3 | Muramidase | – | – | A. baumannii, S. aureus, K. pneumonia, P. aeruginosa, and E. coli | Wu et al. (2018) |